Regulatory Affairs

Medicines
The-vyne health insights can support all types of medicines development programmes covering prescription only, non prescription medicines, biologics and complex treatments today. The-vyne health insights expertise covers wide range of clinical fields, featuring specialist and truly novel treatments globally.

Our Services: 
Regulatory Strategy & Marketing Authorisation Support

Marketing Authorisation – Medicines
We provide end-to-end support for Marketing Authorisation Applications (MAA) in alignment with:

Medicines and Healthcare products Regulatory Agency (MHRA)

European Medicines Agency (EMA)

Our support includes:

Regulatory strategy and pathway selection

Dossier planning and eCTD structure

Module review and submission coordination

Responses to regulatory questions

Post-approval variations and lifecycle management

Medical Devices – UK & EU

We support manufacturers under:

EU Medical Device Regulation (EU MDR)

UK Medical Devices Regulations

Services include:

Device classification and regulatory strategy

CE and UKCA marking preparation

Technical documentation review

Clinical evaluation support

Notified Body readiness

Clinical Trial Applications (CTA)

We provide full regulatory support for clinical trial submissions in the UK and EU.

Services include:

CTA preparation and submission

Protocol and documentation review

Ethics committee coordination

Regulatory responses and amendments

 

  • New Trial Submissions: Supporting preparation of initial CTR-compliant trial applications.
  • Maintenance of Ongoing Trials: Handling substantial and non-substantial modifications, DSUR submissions, and milestone notifications.
  • Document redaction: Ensuring adherence to transparency obligations while safeguarding personal and commercially confidential information.
Information icon

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.